betulinic acid has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| A, H; Mathew, LE; Rajagopal, V | 1 |
1 other study(ies) available for betulinic acid and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
| Article | Year |
|---|---|
Betulinic acid and fluvastatin exhibits synergistic effect on toll-like receptor-4 mediated anti-atherogenic mechanism in type II collagen induced arthritis.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Atherosclerosis; Betulinic Acid; C-Reactive Protein; Collagen Type II; Fatty Acids, Monounsaturated; Female; Fluvastatin; Indoles; Inflammation; Interferon-gamma; Interleukin-10; Interleukin-1beta; Leukocytes, Mononuclear; NF-kappa B; Pentacyclic Triterpenes; Rats; Rats, Sprague-Dawley; Toll-Like Receptor 4; Triterpenes; Tumor Necrosis Factor-alpha | 2017 |